Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence
2016
Background
Clinicians are required to assimilate, critically evaluate, and extrapolate information to support appropriate use of biosimilars across indications.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
118
References
34
Citations
NaN
KQI